Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius SE & Co. KGaA buy tbackenh

Start price
€13.53
16.10.09 / 50%
Target price
€14.27
05.11.09
Performance (%)
5.65%
End price
€14.30
05.11.09
Summary
This prediction ended on 05.11.09 with a price of €14.30. With a performance of 5.65%, the BUY prediction by tbackenh for Fresenius SE & Co. KGaA closed with a slight gain. tbackenh has 50% into this prediction

Fresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius SE & Co. KGaA 3.862% 3.862% 10.789% -30.996%
iShares Core DAX® 0.000% -2.064% 13.111% 16.685%
iShares Nasdaq 100 0.626% -2.884% 37.744% 43.441%
iShares Nikkei 225® 1.568% -5.892% 19.592% 4.617%
iShares S&P 500 0.334% -2.281% 27.745% 41.046%

Comments by tbackenh for this prediction

In the thread Fresenius SE & Co. KGaA diskutieren
Prediction Buy
Perf. (%) 5.65%
Target price 14.267
Change
Ends at 05.11.09

Fresenius SE VZ o.St

Fresenius Medical Care ist der weltweit führende Anbieter von Produkten und Dienstleistungen für Menschen mit chronischem Nierenversagen, von denen sich weltweit mehr als 1,7 Millionen Patienten regelmäßig einer Dialyse-behandlung unterziehen. In einem Netz aus 2.448 Dialysekliniken in Nordamerika, Europa, Asien, Lateinamerika und Afrika betreut Fresenius Medical Care 187.476 Dialysepatienten. Fresenius Medical Care ist ebenfalls der weltweit führende Anbieter von Dialyseprodukten wie Hämodialyse-Geräten, Dialysatoren und damit verbundenen Einweg-Produkten. Fresenius Medical Care ist an der Börse Frankfurt (FME, FME3) und an der Börse New York (FMS, FMS/P) notiert.

Prediction Buy
Perf. (%) 5.65%
Target price 14.267
Change
Ends at 05.11.09

(Vom Mitglied beendet)

Stopped prediction by tbackenh for Fresenius SE & Co. KGaA

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€31.38
20.09.13
€35.00
14.11.13
5.91%
14.11.13

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€13.17
27.02.09
€12.17
09.03.09
-6.43%
09.03.09

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€17.48
19.09.08
€16.47
24.09.08
-5.62%
24.09.08